# Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma Treatment

> **NCT01920516** · — · UNKNOWN · sponsor: **International Group of Endovascular Oncology** · enrollment: 40 (estimated)

## Conditions studied

- Metastatic Melanoma

## Interventions

- **DRUG:** Melphalan

## Key facts

- **NCT ID:** NCT01920516
- **Lead sponsor:** International Group of Endovascular Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07
- **Primary completion:** 2019-06
- **Final completion:** 2020-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01920516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01920516, "Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma Treatment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01920516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*